It has been hypothesized that the normalization of tumor vessels, by the application of antiangiogenic therapies such as antibodies inhibiting VEGF or blocking VEGFR-2, would lead to lowered tumor IFP [2, 8]. This evidence concerns the gene VEGFA and neoplasm.